Abstract  Description  Claims  Drawing  Search report  Cited references 

EP2021065356W   [0064] 
EP21305619A   [0064] 

« Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseases   [0064] 
Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity   [0064] 
Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways   [0064] 
An Efficient and Cost-Effective Nose-Only Inhalational Chamber for Rodents: Design, Optimization and Validation   [0064]